Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06029686 | NOT YET RECRUITING | Parkinson Disease

Vibrotactile Coordinated Reset for Parkinson's Patients of a More Variable Population
Sponsor:

Stanford University

Information provided by (Responsible Party):

Vivek P. Buch

Brief Summary:

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on Parkinson's symptoms of a more variable population. vCR will be administered with a device called the Stanford Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as Levodopa and or deep brain stimulation. Patients will be followed for two years.

Condition or disease

Parkinson Disease

Intervention/treatment

Stanford Glove

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 20 participants
Masking : NONE
Primary Purpose : TREATMENT
Official Title : Vibrotactile Coordinated Reset for Parkinson's Patients of a More Variable Population
Actual Study Start Date : 2025-05
Estimated Primary Completion Date : 2026-12
Estimated Study Completion Date : 2027-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 35 Years to 100 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • 1. Age at the time of enrollment: 35 - 92 years
  • 2. Idiopathic Parkinson's Symptoms between Hoehn and Yahr stages 2 to
  • 3. Fluent in English
  • 4. Comfortable with technology; can use a computer, check email, and access the internet; can initiate and engage in a virtual meeting for training and monitoring purposes.
  • 5. Feels comfortable going off PD related medication during in person study visits
  • 6. Lives in the United States
Exclusion Criteria
  • 1. Any significant neuro-psychiatric problems, including acute confusional state, ongoing psychosis, or suicidal tendencies
  • 2. Any current drug or alcohol abuse.
  • 3. Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days. Any other trial participation should be approved by the Principal Investigators.
  • 4. Pregnancy, breast-feeding or wanting to become pregnant
  • 5. Craniotomy
  • 6. Brain surgery
  • 7. Patient is unable to communicate properly with staff (i.e., severe speech problems)
  • 8. Excessive drooling
  • 9. Patient is taking a medication that may cause significant withdrawal effects
Vibrotactile Coordinated Reset for Parkinson's Patients of a More Variable Population

Location Details

NCT06029686

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

Not yet recruiting

United States, California

Stanford University

Stanford, California, United States, 94305